NEW YORK (GenomeWeb) – Exact Sciences said after the close of the market Monday that it will offer 4 million shares of common stock in a public offering.

The shares are being priced at $25.75 each. The offering, which is expected to close on or around Dec. 19, is pursuant to a previously filed shelf registration with the US Securities and Exchange Commission.

Jefferies and Robert W. Baird are the underwriters on the offering and have been granted an option to purchase up to 600,000 additional shares.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.